Rosuvastatin Calcium Tablet
Product Images NDC 50090-7975

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-7975). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907975)

Label Image (Lbl500907975)
Label for Rosuvastatin Calcium USP 5 mg tablets from A-S Medication Solutions. It includes the product number, dosage strength, storage instructions to keep between 68 to 77 degrees F and protect from moisture, a lot number field, and states 30 tablets per package. The label also mentions the active ingredient as Rosuvastatin Calcium USP equivalent to Rosuvastatin 5 mg.*
FDA Label Image

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)
A Kaplan-Meier plot showing cumulative incidence percentage over 6 years comparing Rosuvastatin (solid line) and Placebo (dotted line). The graph includes hazard ratio (HR 0.56, 95% CI 0.46-0.69) and significance (P<0.001). Below the plot, numbers at risk are detailed for both groups at multiple time points.*
FDA Label Image

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)
A data table showing numbers of events, hazard ratios with 95% confidence intervals, and p-values for various cardiovascular endpoints comparing Rosuvastatin Calcium 20 mg and placebo 20 mg groups. It includes endpoints such as primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization, with a corresponding hazard ratio plot on the right.*
FDA Label Image

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)
A box plot chart displaying percent change from baseline in LDL-C for four drugs: CRESTOR, Atorvastatin, Simvastatin, and Pravastatin. Each drug's LDL-C change is shown at various doses (mg), illustrating dose-dependent effects with ranges and medians for each group.*
FDA Label Image

Structural_formula (Rosuvastatin Tablets Structure)

Structural_formula (Rosuvastatin Tablets Structure)
Chemical structure of rosuvastatin calcium showing its molecular components including rings, hydroxyl groups, and calcium ion component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.